| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.022 | 10.764 | 19.632 | 6.636 | 5.870 | 0 | 0 |
| Total Income - EUR | - | - | - | 1.022 | 10.764 | 19.632 | 6.636 | 5.870 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 964 | 10.448 | 15.204 | 9.618 | 5.055 | 5.506 | 0 |
| Gross Profit/Loss - EUR | - | - | - | 58 | 316 | 4.427 | -2.982 | 815 | -5.506 | 0 |
| Net Profit/Loss - EUR | - | - | - | 28 | -22 | 3.826 | -3.181 | 643 | -5.506 | 0 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Madoc Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 474 | 465 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 1.494 | 3.274 | 8.828 | 708 | 649 | 1.431 | 1.423 |
| Inventories | - | - | - | 867 | 3.117 | 6.268 | 708 | 0 | 0 | 0 |
| Receivables | - | - | - | 168 | 0 | 0 | 0 | 647 | 1.345 | 1.338 |
| Cash | - | - | - | 460 | 157 | 2.560 | 0 | 2 | 86 | 85 |
| Shareholders Funds | - | - | - | 70 | 47 | 3.872 | 667 | 170 | -5.336 | -5.306 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.424 | 3.701 | 5.421 | 41 | 479 | 6.767 | 6.729 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Madoc Pharm S.r.l.